Astrazeneca, Johnson & Johnson to Resume Covid Vaccine Trials in US

0
9
Facebook
Twitter
Pinterest
WhatsApp

Joe Biden said if elected president he would demand that Covid vaccines be free for all Americans

New Delhi:

Drugmakers AstraZeneca and Johnson & Johnson both said on Friday they were set to resume their suspended COVID-19 vaccine trials in the United States – offering a silver lining as the number of cases soared in arrow across the country.

COVID-19 has now killed more than 223,000 Americans, and the health crisis is a major issue in the presidential election pitting Donald Trump against Joe Biden.

Democrat Joe Biden had said that if elected president, he would demand that coronavirus vaccines be free for all Americans, as part of a national strategy to “get ahead” of the coronavirus.

As he laid out his contingency plan to tackle the pandemic, Joe Biden assailed President Donald Trump for his response, claiming the Republican president had “given up” on tackling the virus and “stopped America” .

Donald Trump, who follows Joe Biden in the polls, also stressed that a vaccine – which he says will be ready in the coming weeks – should be free.

Meanwhile, convalescent plasma therapy, which uses blood from recovered COVID-19 patients as a potential treatment, has shown limited effect in reducing progression to serious illness or death in a trial conducted in India, according to scientists.

The study, published in the British Medical Journal (BMJ), involved 464 adults with moderate COVID-19 who were admitted to hospitals in India between April and July.

Here are the updates on the coronavirus (COVID-19) cases:

Coronavirus news: 31 new cases of the virus in Ladakh; total number 5,712

Thirty-one more people have tested positive for COVID-19 in Ladakh, bringing the number of infections in EU territory to 5,712, an official bulletin said on Friday.

So far, 68 people have died from the infection in Ladakh, PTI reported.

LEAVE A REPLY

Please enter your comment!
Please enter your name here